Department of Experimental Obstetrics and Gynecology, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.
Am J Reprod Immunol. 2018 Apr;79(4):e12837. doi: 10.1111/aji.12837. Epub 2018 Feb 28.
Dendritic cells (DCs) are critically involved in fetal fate due to their capability to promote either immunity or tolerance to foreign fetal antigens. Our study aimed to investigate whether the hormone human chorionic gonadotropin (hCG) affects different peripheral blood DC (PBDCs) subsets.
PBDCs were isolated from non-pregnant women, stimulated and co-cultured with hCG-producing JEG-3 or non hCG-producing SWAN-71 trophoblasts as well as with two different hCG preparations. The total and mature number of each PBDC subset were assessed. Additionally, the secretion of cytokines was determined in the presence or absence of hCG.
We found no significant effects; neither from trophoblasts nor from the hCG preparations on PBDC cellularity. JEG-3 cells and both hCG preparations significantly hampered the maturation of MDC1, while SWAN-71 cells did not provoke any changes on this regard. We observed an altered ability of PBDCs to secrete cytokines in the presence of both trophoblasts and both hCG preparations.
Our data propose that hCG is not a key regulator of cellular alterations within PBDCs. However, under inflammatory conditions, hCG seems to keep the delicate balance between PDC and MDC and retains a tolerogenic MDC1 profile and this may contribute to tolerance maintenance.
树突状细胞 (DC) 由于能够促进对外来胎儿抗原的免疫或耐受,因此在胎儿命运中起着至关重要的作用。我们的研究旨在探讨激素人绒毛膜促性腺激素 (hCG) 是否会影响不同的外周血 DC (PBDC) 亚群。
从非孕妇中分离出 PBDC,用产生 hCG 的 JEG-3 或不产生 hCG 的 SWAN-71 滋养层细胞以及两种不同的 hCG 制剂刺激和共培养,并评估每个 PBDC 亚群的总数和成熟数。此外,还在存在或不存在 hCG 的情况下测定细胞因子的分泌情况。
我们发现滋养层细胞或 hCG 制剂对 PBDC 细胞数均无显著影响。JEG-3 细胞和两种 hCG 制剂均显著抑制 MDC1 的成熟,而 SWAN-71 细胞在这方面没有引起任何变化。我们观察到 PBDC 在存在两种滋养层细胞和两种 hCG 制剂时分泌细胞因子的能力发生改变。
我们的数据表明,hCG 不是 PBDC 细胞内细胞变化的关键调节剂。然而,在炎症条件下,hCG 似乎维持了 PDC 和 MDC 之间的微妙平衡,并保持了耐受的 MDC1 表型,这可能有助于维持耐受。